Exotic emerging viral diseases: progress and challenges (original) (raw)

• Geisbert, T.W., Pushko, P., Anderson, K., Smith, J. & Davis, K.J. & Jahrling, P.B. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg. Infect. Dis. 8, 503–507 (2002).
  Article PubMed PubMed Central Google Scholar
• Walker, D.H. & Murphy, F.A. Pathology and pathogenesis of arenavirus infections. Curr. Top. Microbiol. Immunol. 133, 89–113 (1987).
  CAS PubMed Google Scholar
• WHO. Ebola haemorrhagic fever in Sudan, 1976. Report of an international study team. Bull. World Health Organ. 56, 247–270 (1978).
• WHO. Ebola haemorrhagic fever in Zaire, 1976. Report of an international commission. Bull. World Health Organ. 56, 271–293 (1978).
• Khan, A.S. et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179 Suppl 1, S76–S86 (1999).
  Article PubMed Google Scholar
• Fisher-Hoch, S.P. et al. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J. Infect. Dis. 155, 465–474 (1987).
  Article CAS PubMed Google Scholar
• Morrill, J.C. et al. Pathogenesis of Rift Valley fever in rhesus monkeys: role of the interferon response. Arch. Virol. 110, 195–212 (1990).
  Article CAS PubMed Google Scholar
• Fisher-Hoch, S.P. et al. Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management. Lancet 2, 1055–1058 (1983).
  Article CAS PubMed Google Scholar
• Fisher-Hoch, S.P. et al. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J. Infect. Dis. 152, 887–894 (1985).
  Article CAS PubMed Google Scholar
• Jaax, N.K. et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch. Pathol. Lab. Med. 120, 140–155 (1996).
  CAS PubMed Google Scholar
• Geisbert, T.W. et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol. 163, 2347–2370 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Elsner, B., Schwarz, E., Mando, O.G., Maiztegui, J. & Vilches, A. Pathology of 12 fatal cases of Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 22, 229–236 (1973).
  Article CAS PubMed Google Scholar
• McKee, K.T., Jr, Mahlandt, B.G., Maiztegui, J.I., Green, D.E. & Peters, C.J. Virus-specific factors in Argentine hemorrhagic fever in rhesus macaques. J. Med. Virol. 22, 99–111 (1987).
  Article PubMed Google Scholar
• Monath, T.P. & Barrett, A.D. Pathogenesis and pathophysiology of yellow fever. Adv. Virus Res. 60, 343–395 (2003).
  Article PubMed Google Scholar
• Maiztegui, J.I. et al. Ultrastructural and immunohistochemical studies in five cases of Argentine hemorrhagic fever. J. Infect. Dis. 132, 35–53 (1975).
  Article CAS PubMed Google Scholar
• Jahrling, P.B. et al. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J. Infect. Dis. 141, 580–589 (1980).
  Article CAS PubMed Google Scholar
• Gonzalez, P.H., Cossio, P.M., Arana, R., Maiztegui, J.I. & Laugens, R.P. Lymphatic tissue in Argentine hemorrhagic fever. Pathologic features. Arch. Pathol. Lab. Med. 104, 250–254 (1980).
  CAS PubMed Google Scholar
• De Brito, T. et al. Human fatal yellow fever. Immunohistochemical detection of viral antigens in the liver, kidney and heart. Pathol. Res. Pract. 188, 177–181 (1992).
  Article CAS PubMed Google Scholar
• Geisbert, T.W., Jahrling, P.B., Hanes, M.A. & Zack, P.M. Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. J. Comp. Pathol. 106, 137–152 (1992).
  Article CAS PubMed Google Scholar
• Burt, F.J. et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 121, 839–846 (1997).
  CAS PubMed Google Scholar
• Geisbert, T.W. & Jaax, N.K. Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy. Ultrastruct. Pathol. 22, 3–17 (1998).
  Article CAS PubMed Google Scholar
• Zaki, S.R. & Goldsmith, C.S. Pathologic features of filovirus infections in humans. Curr. Top. Microbiol. Immunol. 235, 97–116 (1999).
  CAS PubMed Google Scholar
• de Filippis, A.M. et al. Outbreak of jaundice and hemorrhagic fever in the Southeast of Brazil in 2001: detection and molecular characterization of yellow fever virus. J. Med. Virol. 68, 620–627 (2002).
  Article CAS PubMed Google Scholar
• Geisbert, T.W. et al. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am. J. Pathol. 163, 2371–2382 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Becker, S., Spiess, M. & Klenk, H.D. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J. Gen. Virol. 76, 393–399 (1995).
  Article CAS PubMed Google Scholar
• Chan, S.Y. et al. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 106, 117–126 (2001).
  Article CAS PubMed Google Scholar
• Alvarez, C.P. et al. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76, 6841–6844 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Simmons, G. et al. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305, 115–123 (2003).
  Article CAS PubMed Google Scholar
• Marzi, A. et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J. Virol. 78, 12090–12095 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Takada, A. et al. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278, 20–26 (2000).
  Article CAS PubMed Google Scholar
• Takada, A. et al. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J. Virol. 78, 2943–2947 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Cao, W. et al. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282, 2079–2081 (1998).
  Article CAS PubMed Google Scholar
• Spiropoulou, C.F., Kunz, S., Rollin, P.E., Campbell, K.P. & Oldstone, M.B. New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J. Virol. 76, 5140–5146 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Gallaher, W.R., DiSimone, C. & Buchmeier, M.J. The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor. BMC Microbiol. 1, http://www.biomedcentral.com/1471-2180/1/1 (2001).
• Yang, Z. et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6, 886–889 (2000).
  Article CAS PubMed Google Scholar
• Lukashevich, I.S. et al. Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J. Med. Virol. 59, 552–560 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Gear, J.S. et al. Outbreake of Marburg virus disease in Johannesburg. Br. Med. J. 4, 489–493 (1975).
  Article CAS PubMed PubMed Central Google Scholar
• Murphy, F.A. Pathology of Ebola virus infection, in Ebola Virus Haemorrhagic Fever (ed Pattyn, S.R.) (Elsevier/North-Holland Biomedical Press, New York, 1978).
  Google Scholar
• Terrell, T.G., Stookey, J.L., Eddy, G.A. & Kastello, M.D. Pathology of Bolivian hemorrhagic fever in the rhesus monkey. Am. J. Pathol. 73, 477–494 (1973).
  CAS PubMed PubMed Central Google Scholar
• Feldmann, H. et al. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J. Virol. 70, 2208–2214 (1996).
  CAS PubMed PubMed Central Google Scholar
• Callis, R.T., Jahrling, P.B. & DePaoli, A. Pathology of Lassa virus infection in the rhesus monkey. Am. J. Trop. Med. Hyg. 31, 1038–1045 (1982).
  Article CAS PubMed Google Scholar
• Frame, J.D. Clinical features of Lassa fever in Liberia. Rev. Infect. Dis. 11 Suppl 4, S783–S789 (1989).
  Article PubMed Google Scholar
• Child, P.L., MacKenzie, R.B., Valverde, L.R. & Johnson, K.M. Bolivian hemorrhagic fever: a pathological description. Arch. Pathol. 83, 434–445 (1967).
  CAS PubMed Google Scholar
• Gedigk, P., Bechtelsheimer, H. & Korb, G. Pathologic anatomy of the Marburg virus disease, in Marburg Virus Disease (eds Martini, G.A. & Siegert, R.) (Springer-Verlag, New York, 1971).
  Google Scholar
• Winn, W.C., Jr & Walker, D.H. The pathology of human Lassa fever. Bull. World Health Organ. 52, 535–545 (1975).
  PubMed PubMed Central Google Scholar
• Walker, D.H. et al. Pathologic and virologic study of fatal Lassa fever in man. Am. J. Pathol. 107, 349–356 (1982).
  CAS PubMed PubMed Central Google Scholar
• Green, D.E., Mahlandt, B.G. & McKee, K.T., Jr. Experimental Argentine hemorrhagic fever in rhesus macaques: virus-specific variations in pathology. J. Med. Virol. 22, 113–133 (1987).
  Article CAS PubMed Google Scholar
• Elton, N.W., Romero, A. & Trejos, A. Clinical pathology of yellow fever. Am. J. Clin. Pathol. 25, 135–146 (1955).
  Article CAS PubMed Google Scholar
• Martini, G.A. Marburg virus disease: clinical syndrome, in Marburg Virus Disease (eds Martini, G.A. & Siegert, R.) (Springer-Verlag, New York, 1971).
  Chapter Google Scholar
• Joubert, J.R., King, J.B., Rossouw, D.J. & Cooper, R. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis. S. Afr. Med. J. 68, 722–728 (1985).
  CAS PubMed Google Scholar
• Peters, C.J., Jahrling, P.B., Liu, C.T., Kenyon, R.H. & McKee, K.T., Jr. & Barrera Oro, J.G. Experimental studies of arenaviral hemorrhagic fevers. Curr. Top. Microbiol. Immunol. 134, 5–68 (1987).
  CAS PubMed Google Scholar
• Peters, C.J. et al. Experimental Rift Valley fever in rhesus macaques. Arch. Virol. 99, 31–44 (1988).
  Article CAS PubMed Google Scholar
• Fisher-Hoch, S.P., McCormick, J.B., Sasso, D. & Craven, R.B. Hematologic dysfunction in Lassa fever. J. Med. Virol. 26, 127–135 (1988).
  Article CAS PubMed Google Scholar
• Swanepoel, R. et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11 Suppl 4, S794–S800 (1989).
  Article PubMed Google Scholar
• Fisher-Hoch, S.P. et al. Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. J. Infect. Dis. 166, 753–763 (1992).
  Article CAS PubMed Google Scholar
• Sanchez, A. et al. Filoviridae: Marburg and Ebola viruses, in Fields Virology (eds Knipe, D.S. & Howley, P.M.) (Lippincott Williams & Wilkins, Philadelphia, 2001).
  Google Scholar
• Schmitz, H. et al. Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect. 4, 43–50 (2002).
  Article PubMed Google Scholar
• Ergonul, O. et al. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin. Infect. Dis. 39, 284–287 (2004).
  Article PubMed Google Scholar
• McLeod, C.G., Jr, Stookey, J.L., White, J.D., Eddy, G.A. & Fry, G.A. Pathology of Bolivian Hemorrhagic fever in the African green monkey. Am. J. Trop. Med. Hyg. 27, 822–826 (1978).
  Article PubMed Google Scholar
• Peters, C.J. Arenaviruses, in Clincal Virology (Eds Richman, D.D., Whitley, R.J. & Hayden, F.G.) (Churchill Livingstone, New York, 1997).
  Google Scholar
• Hudson, N. The pathology of experimental yellow fever in the Macaca rhesus. III. Comparison with the pathology of yellow fever in man. Am. J. Pathol. 4, 419–439 (1928).
  CAS PubMed PubMed Central Google Scholar
• Klotz, O. & Belt, T.H. Pathology in spleen in yellow fever. Am. J. Pathol. 6, 655–662 (1930).
  CAS PubMed PubMed Central Google Scholar
• Zlotnik, I. Marburg agent disease: Pathology. Trans. R. Soc. Trop. Med. Hyg. 63, 310–323 (1969).
  Article CAS PubMed Google Scholar
• Murphy, F.A., Simpson, D.I.H., Whitfield, S.G., Zlotnik, I. & Carter, G.B. Marburg virus infection in monkeys. Lab. Invest. 24, 279–291 (1971).
  CAS PubMed Google Scholar
• Edington, G.M. & White, H.A. The pathology of Lassa fever. Trans. R. Soc. Trop. Med. Hyg. 66, 381–389 (1972).
  Article CAS PubMed Google Scholar
• Monath, T.P., Brinker, K.R., Chandler, F.W., Kemp, G.E. & Cropp, C.B. Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues. Am. J. Trop. Med. Hyg. 30, 431–443 (1981).
  Article CAS PubMed Google Scholar
• Baskerville, A., Satti, A., Murphy, F.A. & Simpson, D.I. Congo-Crimean haemorrhagic fever in Dubai: histopathological studies. J. Clin. Pathol. 34, 871–874 (1981).
  Article CAS PubMed PubMed Central Google Scholar
• Simpson, D.I.H. Marburg agent disease: in monkeys. Trans. R. Soc. Trop. Med. Hyg. 63, 303–309 (1969).
  Article CAS PubMed Google Scholar
• Havemann, K. & Schmidt, H.A. Haematological findings in Marburg virus disease: evidence for involvement of the immunological system, in Marburg Virus Disease (eds Martini, G.A. & Siegert, R.) (Springer-Verlag, New York, 1971).
  Google Scholar
• Kastello, M.D., Eddy, G.A. & Kuehne, R.W. A rhesus monkey model for the study of Bolivian hemorrhagic fever. J. Infect. Dis. 133, 57–62 (1976).
  Article CAS PubMed Google Scholar
• Wagner, F.S., Eddy, G.A. & Brand, O.M. The African green monkey as an alternate primate host for studying Machupo virus infection. Am. J. Trop. Med. Hyg. 26, 159–162 (1977).
  Article CAS PubMed Google Scholar
• Fisher-Hoch, S.P. et al. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 86, 317–321 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Vallejos, D.A., Ambrosio, A.M., Feuillade, M.R. & Maiztegui, J.I. Lymphocyte subsets alteration in patients with Argentine hemorrhagic fever. J. Med. Virol. 27, 160–163 (1989).
  Article CAS PubMed Google Scholar
• Sanchez, A. et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J. Virol. 78, 10370–10377 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Baize, S. et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 5, 423–426 (1999).
  Article CAS PubMed Google Scholar
• Geisbert, T.W. et al. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab. Invest. 80, 171–186 (2000).
  Article CAS PubMed Google Scholar
• Reed, D.S., Hensley, L.E., Geisbert, J.B., Jahrling, P.B. & Geisbert, T.W. Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques. Viral Immunol. 17, 390–400 (2004).
  Article CAS PubMed Google Scholar
• Hensley, L.E., Young, H.A., Jahrling, P.B. & Geisbert, T.W. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol. Lett. 80, 169–179 (2002).
  Article CAS PubMed Google Scholar
• Takabayashi, A. et al. Nitric oxide induces a decrease in the mitochondrial membrane potential of peripheral blood lymphocytes, especially in natural killer cells. Antioxid. Redox Signal. 2, 673–680 (2000).
  Article CAS PubMed Google Scholar
• Mahanty, S. et al. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170, 2797–2801 (2003).
  Article CAS PubMed Google Scholar
• Daniel, P.T., Scholz, C., Westermann, J., Dorken, B. & Pezzutto, A. Dendritic cells prevent CD95 mediated T lymphocyte death through costimulatory signals. Adv. Exp. Med. Biol. 451, 173–177 (1998).
  Article CAS PubMed Google Scholar
• Baize, S. et al. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 172, 2861–2869 (2004).
  Article CAS PubMed Google Scholar
• Raftery, M.J. et al. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15, 997–1009 (2001).
  Article CAS PubMed Google Scholar
• Volchkov, V.E., Blinov, V.M. & Netesov, S.V. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett. 305, 181–184 (1992).
  Article CAS PubMed Google Scholar
• Bukreyev, A., Volchkov, V.E., Blinov, V.M. & Netesov, S.V. The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins. FEBS Lett. 323, 183–187 (1993).
  Article CAS PubMed Google Scholar
• Calandra, T., Gerain, J., Heumann, D. & Baumgartner, J.D. & Glauser MP. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am. J. Med. 91, 23–29 (1991).
  Article CAS PubMed Google Scholar
• Damas, P. et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215, 356–362 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Marty, C. et al. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit. Care Med. 22, 673–679 (1994).
  Article CAS PubMed Google Scholar
• Levis, S.C. et al. Endogenous interferon in Argentine hemorrhagic fever. J. Infect. Dis. 149, 428–433 (1984).
  Article CAS PubMed Google Scholar
• Levis, S.C. et al. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J. Interferon Res. 5, 383–389 (1985).
  Article CAS PubMed Google Scholar
• Heller, M.V., Saavedra, M.C., Falcoff, R., Maiztegui, J.I. & Molinas, F.C. Increased tumor necrosis factor-alpha levels in Argentine hemorrhagic fever. J. Infect. Dis. 166, 1203–1204 (1992).
  Article CAS PubMed Google Scholar
• Marta, R.F. et al. Proinflammatory cytokines and elastase-α-1-antitrypsin in Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 60, 85–89 (1999).
  Article CAS PubMed Google Scholar
• Villinger, F. et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 179 Suppl 1, S188–S191 (1999).
  Article CAS PubMed Google Scholar
• Ignatiev, G.M., Dadaeva, A.A., Luchko, S.V. & Chepurnov, A.A. Immune and pathophysiological processes in baboons experimentally infected with Ebola virus adapted to guinea pigs. Immunol. Lett. 71, 131–140 (2000).
  Article CAS PubMed Google Scholar
• Mahanty, S. et al. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J. Infect. Dis. 183, 1713–1721 (2001).
  Article CAS PubMed Google Scholar
• Ter Meulen, J. et al. Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J. Infect. Dis. 190, 1821–1827 (2004).
  Article CAS PubMed Google Scholar
• Stroher, U. et al. Infection and activation of monocytes by Marburg and Ebola viruses. J. Virol. 75, 11025–11033 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Gomez, R.M. et al. Endothelial cell function alteration after Junin virus infection. Thromb. Haemost. 90, 326–333 (2003).
  Article CAS PubMed Google Scholar
• Leroy, E.M. et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355, 2210–2215 (2000).
  Article CAS PubMed Google Scholar
• Peters, C.J., Liu, C.T., Anderson, G.W., Jr, Morrill, J.C. & Jahrling, P.B. Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev. Infect. Dis. 11 Suppl 4, S743–S749 (1989).
  Article PubMed Google Scholar
• Asper, M. et al. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J. Virol. 78, 3162–3169 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Foster, G.R. & Finter, N.B. Are all type I human interferons equivalent? J. Viral Hepat. 5, 143–152 (1998).
  Article CAS PubMed Google Scholar
• Basler, C.F. et al. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA 97, 12289–12294 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Basler, C.F. et al. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77, 7945–7956 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Basler, C.F. & Palese, P. Modulation of innate immunity by filoviruses, in Ebola and Marburg viruses: molecular and cellular biology (eds Klenk, H.D. & Feldmann, H) (Horizon Bioscience, Norfolk, UK, 2004).
  Google Scholar
• Bouloy, M. et al. Genetic evidence for an interferon-antagonist function of rift valley fever virus nonstructural protein NSs. J. Virol. 75, 1371–1377 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Li, H. & Forstermann, U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190, 244–254 (2000).
  Article CAS PubMed Google Scholar
• Mammen, E.F. Disseminated intravascular coagulation (DIC). Clin. Lab. Sci. 13, 239–245 (2000).
  CAS PubMed Google Scholar
• Levi, M. Current understanding of disseminated intravascular coagulation. Br. J. Haematol. 124, 567–576 (2004).
  Article PubMed Google Scholar
• Martini, G.A., Knauff, H.G., Schmidt, H.A., Mayer, G. & Baltzer, G. A hitherto unknown infectious disease contracted from monkeys. “Marburg-virus” disease. Ger. Med. Mon. 13, 457–470 (1968).
  CAS PubMed Google Scholar
• Bwaka, M.A. et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J. Infect. Dis. 179 suppl. Suppl 1, S1–S7 (1999).
  Article PubMed Google Scholar
• Bowen, E.T., Platt, G.S., Simpson, D.I., McArdell, L.B. & Raymond, R.T. Ebola haemorrhagic fever: experimental infection of monkeys. Trans. R. Soc. Trop. Med. Hyg. 72, 188–191 (1978).
  Article CAS PubMed Google Scholar
• Geisbert, T.W. et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 362, 1953–1958 (2003).
  Article CAS PubMed Google Scholar
• Mackenzie, R.B., Beye, H.K. & Valverde, L. & Garr'on, H. Epidemic hemorrhagic fever in Bolivia. I. A preliminary report of the epidemiological and clinical findings in a new epidemic area in South America. Am. J. Trop. Med. Hyg. 13, 620–625 (1964).
  Article CAS PubMed Google Scholar
• Peters, C.J., Zaki, S.R. & Rollin, P.E. Viral hemorrhagic fevers, in Atlas of Infectious Diseases Vol. 3 (ed Feteky, R.) (Churchill Livingstone, Philadelphia, 1997).
  Google Scholar
• Molinas, F.C., de Bracco, M.M. & Maiztegui, J.I. Coagulation studies in Argentine hemorrhagic fever. J. Infect. Dis. 143, 1–6 (1981).
  Article CAS PubMed Google Scholar
• Dennis, L.H., Reisberg, B.E., Crosbie, J., Crozier, D. & Conrad, M.E. The original haemorrhagic fever: yellow fever. Br. J. Haematol. 17, 455–462 (1969).
  Article CAS PubMed Google Scholar
• Scott, S.K. et al. Studies of the coagulation system and blood pressure during experimental Bolivian hemorrhagic fever in rhesus monkeys. Am. J. Trop. Med. Hyg. 27, 1232–1239 (1978).
  Article CAS PubMed Google Scholar
• Molinas, F.C. et al. Alteration of blood coagulation and complement system in neotropical primates infected with Junin virus. J. Med. Virol. 12, 281–292 (1983).
  Article CAS PubMed Google Scholar
• Salas, R. et al. Venezuelan haemorrhagic fever. Lancet 338, 1033–1036 (1991).
  Article CAS PubMed Google Scholar
• Heller, M.V. et al. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever. Thromb. Haemost. 73, 368–373 (1995).
  CAS PubMed Google Scholar
• Geisbert, T.W. et al. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J. Infect. Dis. 188, 1618–1629 (2003).
  Article CAS PubMed Google Scholar
• Knobloch, J. et al. Clinical obersvations in 42 patients with Lassa fever. Tropenmed. Parasitol. 31, 389–398 (1980).
  CAS PubMed Google Scholar
• Lange, J.V. et al. Kinetic study of platelets and fibrinogen in Lassa virus-infected monkeys and early pathologic events in Mopeia virus-infected monkeys. Am. J. Trop. Med. Hyg. 34, 999–1007 (1985).
  Article CAS PubMed Google Scholar
• Rippey, J.J., Schepers, N.J. & Gear, J.H. The pathology of Marburg virus disease. S. Afr. Med. J. 66, 50–54 (1984).
  CAS PubMed Google Scholar
• Isaacson, M., Sureua, P., Courtielle, G. & Pattyn, S.R. Clinical aspects of Ebola virus disease at the Ngaliema hospital, Kinshasa, Zaire, 1976, in Ebola Virus Haemorrhagic Fever (ed. Pattyn, S.R.) (Elsevier/North-Holland Biomedical Press, New York, 1978).
  Google Scholar
• Santos, F. et al. Coagulacao intravascular diseminada aguda na febre amarela: dosagem dos factores da coagulacao. Brasilia Med. 9, 9–16 (1973).
  Google Scholar
• Grignani, G. & Maiolo, A. Cytokines and hemostasis. Haematologica 85, 967–972 (2000).
  CAS PubMed Google Scholar
• Neumann, F-J. et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler. Thromb. Vasc. Biol. 17, 3399–3405 (1997).
  Article CAS PubMed Google Scholar
• Volchkov, V.E. et al. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 291, 1965–1969 (2001).
  Article CAS PubMed Google Scholar
• Neumann, G., Feldmann, H., Watanabe, S., Lukashevich, I. & Kawaoka, Y. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J. Virol. 76, 406–410 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Flick, R., Flick, K., Feldmann, H. & Elgh, F. Reverse genetics for Crimean-Congo hemorrhagic fever virus. J. Virol. 77, 5997–6006 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bredenbeek, P.J. et al. A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J. Gen. Virol. 84, 1261–1268 (2003).
  Article CAS PubMed Google Scholar
• Rubins, K.H. et al. Systematic analysis of the gene expression program in peripheral blood cells in response to systemic smallpox infection. Proc. Natl. Acad. Sci. USA 101, 15190–15195 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Emmert-Buck, M.R. et al. Laser capture microdissection. Science 274, 998–1001 (1996).
  Article CAS PubMed Google Scholar
• Bonner, R.F. et al. Laser capture microdissection: molecular analysis of tissue. Science 278, 1481, 1483 (1997).
  Article CAS PubMed Google Scholar
• Alibek, K. & Handelman, S. Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World. Told From the Inside by the Man Who Ran It (Random House, New York, 1999).
  Google Scholar
• Monath, T.P. Yellow fever: an update. Lancet Infect. Dis. 1, 11–20 (2001).
  Article CAS PubMed Google Scholar
• Maiztegui, J.I. et al. (1998) Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. J. Infect. Dis. 177, 277–283 (1998).
  Article CAS PubMed Google Scholar
• Pittman, P.R. et al. Immunogenicity of an inactivated Rift Valley fever vaccine in humans. Vaccine 18, 181–189 (1999).
  Article CAS PubMed Google Scholar
• Geisbert, T.W. & Jahrling, P.B. Towards a vaccine against Ebola virus. Expert Rev. Vaccines 2, 777–789 (2003).
  Article PubMed Google Scholar
• Fisher-Hoch, S.P. & McCormick, J.B. Lassa fever vaccine. Expert Rev. Vaccines 3, 189–197 (2004).
  Article CAS PubMed Google Scholar
• Fisher-Hoch, S.P., Hutwagner, L., Brown, B. & McCormick, J.B. Effective vaccine for Lassa fever. J. Virol. 74, 6777–6783 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z-Y. & Nabel, G.J. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408, 605–609 (2000).
  Article CAS PubMed Google Scholar
• Sullivan, N.J. et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424, 681–684.
• Jones, S. et al. Replicating vectors for vaccine development. VRC Symposium on Viral Hemorrhagic Fevers, Bethesda, MD, October 14–17, 2003.
• International Society for Infectious Diseases. Ebola, lab accident death - Russia (Siberia), May 22, 2004. Archive no. 20040522.1377. http://www.promedmail.org (2004).
• Huggins, J., Zhang, Z.X. & Bray, M. Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model. J. Infect. Dis. 179 Suppl 1, S240–S247 (1999).
  Article CAS PubMed Google Scholar
• Huggins, J.W., Zhang, Z.X., Davis, K. & Coulombe, R.A. Inhibition of Ebola virus by S-adenosylhomocysteine hydrolase inhibitors. Antiviral Res. 26, A301 (1995).
  Article Google Scholar
• Canonico, P.G., Kende, M., Luscri, B.J. & Huggins, J.W. In-vivo activity of antivirals against exotic RNA viral infections. J. Antimicrob. Chemother. 14, 27–41 (1984).
  Article CAS PubMed Google Scholar
• McCormick, J.B. et al. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314, 20–26 (1986).
  Article CAS PubMed Google Scholar
• Centers for Disease Control. Management of patients with suspected viral hemorrhagic fever. Morb. Mortal. Wkly. Rep. 37 Suppl 3, 1–16 (1988).
• Huggins, J.W. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev. Infect. Dis. 11 Suppl 4, S750–S761 (1989).
  Article CAS PubMed Google Scholar
• Fisher-Hoch, S.P. et al. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 346, 472–475 (1995).
  Article CAS PubMed Google Scholar
• Kilgore, P.E. et al. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin. Infect. Dis. 24, 718–722 (1997).
  Article CAS PubMed Google Scholar
• Mardani, M., Jahromi, M.K., Naieni, K.H. & Zeinali, M. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran. Clin. Infect. Dis. 36, 1613–1618 (2003).
  Article CAS PubMed Google Scholar
• Ignat'ev, G.M., Strel'tsova, M.A., Agafonov, A.P., Kashentseva, E.A. & Prozorovskii, N.S. Experimental study of possible treatment of Marburg hemorrhagic fever with desferal, ribavirin, and homologous interferon. Vopr. Virusol. 41, 206–209 (1996).
  CAS PubMed Google Scholar
• Jahrling, P.B. et al. Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J. Infect. Dis. 179 Suppl 1, S224–S234 (1999).
  Article CAS PubMed Google Scholar
• Morrill, J.C., Jennings, G.B., Cosgriff, T.M., Gibbs, P.H. & Peters, C.J. (1989) Prevention of Rift Valley fever in rhesus monkeys with interferon-α. Rev. Infect. Dis. 11 Suppl 4, S815–S825 (1989).
  Article CAS PubMed Google Scholar
• Morrill, J.C., Czarniecki, C.W. & Peters, C.J. Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey. J. Interferon Res. 11, 297–304 (1991).
  Article CAS PubMed Google Scholar
• Leifer, E., Gocke, D.J. & Bourne, H. Lassa fever, a new virus disease in man from West Africa, II: report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. Am. J. Trop. Med. Hyg. 19, 677–679 (1970).
  Article CAS PubMed Google Scholar
• Emond, R.T., Evans, B., Bowen, E.T. & Lloyd, G. A case of Ebola virus infection. Br. Med. J. 2, 541–544 (1977).
  Article CAS PubMed PubMed Central Google Scholar
• Maiztegui, J.I., Fernandez, N.J. & de Damilano, A.J. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 2, 1216–1217 (1979).
  Article CAS PubMed Google Scholar
• Enria, D.A., Briggiler, A.M., Fernandez, N.J., Lewis, S.C. & Maiztegui, J.I. Importance of dose of neutralizing antibodies in treatment of Argentine hemorrhagic fever with immune plasma. Lancet 2, 255–256 (1984).
  Article CAS PubMed Google Scholar
• Frame, J.D., Verbrugge, G.P., Gill, R.G. & Pinneo, L. The use of Lassa fever convalescent plasma in Nigeria. Trans. R. Soc. Trop. Med. Hyg. 78, 319–324 (1984).
  Article CAS PubMed Google Scholar
• Mupapa, K. et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J. Infect. Dis. 179 Suppl 1, S18–S23 (1999).
  Article PubMed Google Scholar
• White, H.A. Lassa fever: a study of 23 hospital cases. Trans. R. Soc. Trop. Med. Hyg. 66, 390–401 (1972).
  Article CAS PubMed Google Scholar
• Clayton, A.J. (1977) Lassa immune serum. Bull. World Health Organ. 55, 435–439 (1977).
  CAS PubMed PubMed Central Google Scholar
• Jahrling, P.B., Frame, J.D., Rhoderick, J.B. & Monson, M.H. Endemic Lassa fever in Liberia, IV: selection of optimally effective plasma for treatment by passive immunization. Trans. R. Soc. Trop. Med. Hyg. 79, 380–384 (1985).
  Article CAS PubMed Google Scholar
• Shepherd, A.J., Swanepoel, R. & Leman, P.A. Antibody response in Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11 Suppl 4, S801–S806 (1989).
  Article PubMed Google Scholar
• Ge, Q. et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA 101, 8676–8681 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Miura, Y. et al. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J. Exp. Med. 193, 651–660 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Q., Miyakawa, Y., Fox, N. & Kaushansky, K. Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Blood 96, 2093–2099 (2000).
  CAS PubMed Google Scholar
• Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H. & Okumura, K. & Yagita, H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 189, 1451–1460 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Schnittler, H-J. & Feldmann, H. Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages? Clin. Infect. Dis. 27, 404–406 (1998).
  Article CAS PubMed Google Scholar